Contraceptive Technology Update – March 1, 2007
March 1, 2007
View Issues
-
U.S. teen pregnancy rates decline due to improved contraceptive use
Results of a new analysis of national data indicate that 86% of the recent drop in U.S. teen pregnancy rates is the result of improved contraceptive use, while 14% of the decline can be attributed to teens waiting longer to start having sex. -
Research supports safety of continuous regimen pill
Research regarding the safety and efficacy of the first continuous regimen oral contraceptive (OC) has just been published, with results indicating a good safety profile and efficacy similar to cyclic OCs. -
Hormonal contraception use doesn't up HIV risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, according to results from a new study commissioned by the National Institute of Child Health and Human Development (NICHD). -
Adult male circumcision reduces risk for HIV
Two clinical trials of adult male circumcision have been halted after an interim review of data showed medically performed circumcision significantly lowers a man's risk of acquiring HIV through heterosexual intercourse. -
Support is growing for HPV vaccine for girls
Acceptance of the first human papillomavirus (HPV) vaccine continues to grow, as the national immunization schedule for children and teens has been updated to include Gardasil, manufactured by Merck & Co., of Whitehouse Station, NJ. -
Trichomoniasis in men — common, often undetected
As you review the chart for your next patient, a heterosexual women seeking treatment for a yellow-green vaginal discharge and vulvar irritation, you see her test results are positive for trichomoniasis. When you discuss the test results with the patient, she tells you her partner has had no symptoms of infection.